Substance Use and Psychiatric Symptoms Among MCMI-III Cluster Subgroups

2006 ◽  
Author(s):  
Robert C. McMahon ◽  
Robert M. Malow ◽  
Jessy Devieux ◽  
Terri Jennings
PEDIATRICS ◽  
2003 ◽  
Vol 111 (6) ◽  
pp. e699-e705 ◽  
Author(s):  
L. A. Shrier ◽  
S. K. Harris ◽  
M. Kurland ◽  
J. R. Knight

2004 ◽  
Vol 5 (4) ◽  
pp. 199-202 ◽  
Author(s):  
Robert J. Calsyn ◽  
Gary A. Morse ◽  
W. Dean Klinkenberg ◽  
Matthew R. Lemming

This study examined the relationship between outcomes and the working alliance in clients who were receiving assertive community treatment only or integrated assertive community treatment (assertive community treatment plus substance abuse treatment). All 98 participants had a severe mental illness and a substance use disorder. The Working Alliance Inventory assessed the alliance from the perspective of both the client and the case manager at 3 and 15 months into treatment. The six outcome measures were stable housing, client rating of psychiatric distress, interviewer rating of psychiatric symptoms, self-report of days used alcohol or drugs, and interviewer rating of substance use. Only 4 of 24 correlations were significant, indicating little relationship between the strength of the working alliance and client outcome.


Author(s):  
Steven A. Eraker

Addressed equally to psychiatrists and to primary care providers, this chapter is intended to explore non–substance use disorder psychiatric diagnoses as they impact the perception of pain and the treatment of substance use disorders. A screening checklist emphasizing basic principles of psychiatric history-taking is provided to help identify the patient’s requirements. The author reviews the classes of psychiatric diagnoses most likely to be present in the pain/addiction and other comorbidly-ill patients, and reviews suicide risks. Similarly, the classes of medications employed in psychiatry and their capacity for alleviation or aggravation of substance use disorders are reviewed, with notations of drug–drug interactions. A final section addresses the role of emotions and psychiatric symptoms in the perception and management of pain.


2020 ◽  
Vol 9 (6) ◽  
pp. 1913
Author(s):  
Pier Paolo Pani ◽  
Angelo G. I. Maremmani ◽  
Matteo Pacini ◽  
Emanuela Trogu ◽  
Gian Luigi Gessa ◽  
...  

The diagnosis of substance use disorder is currently based on the presence of specifically identified behavioral symptoms. In addition, other psychiatric signs and symptoms accompany addictive behavior, contributing to the full picture of patients’ psychopathologic profile. Historically, such symptoms were confined within the framework of “comorbidity”, as comorbid psychiatric disorders or personality traits. However, an alternative unitary view of the psychopathology of addiction, inclusive of related psychiatric symptoms, has been claimed, with the support of epidemiological, neurobiological, and neuropsychological evidence. In the present article, we highlight the research advancements that strengthen this unified perspective. We then give an account of our group’s definition of a specific SCL-90-based construct of the psychopathology of addiction. Lastly, we discuss the benefits that can be expected to be acquired in the evaluation and treatment of patients with a longitudinal approach including psychological/psychiatric predisposing features, addictive behavior, and psychiatric manifestations.


2017 ◽  
Vol 53 (4) ◽  
pp. 383-393 ◽  
Author(s):  
Lourah M. Kelly ◽  
Sara J. Becker ◽  
Jennifer C. Wolff ◽  
Hannah Graves ◽  
Anthony Spirito

Sign in / Sign up

Export Citation Format

Share Document